We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.3B
AUM Growth
+$783M
(+4.2%)
Cap. Flow
-$455M
Cap. Flow
% of AUM
-2.35%
Top 10 Holdings %
Top 10 Hldgs %
20.28%
Holding
1,342
New
146
Increased
332
Reduced
638
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$37.2M |
| 2 |
Progressive
PGR
|
+$34.8M |
| 3 |
Northrop Grumman
NOC
|
+$24.6M |
| 4 |
Revvity
RVTY
|
+$24.1M |
| 5 |
Carrier Global
CARR
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.9M |
| 2 |
Fortinet
FTNT
|
+$36.2M |
| 3 |
Ameriprise Financial
AMP
|
+$35.9M |
| 4 |
Cadence Design Systems
CDNS
|
+$31M |
| 5 |
Broadstone Net Lease
BNL
|
+$30.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Healthcare | 12.4% |
| 3 | Financials | 11.64% |
| 4 | Consumer Discretionary | 9.19% |
| 5 | Industrials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
HEICO Corp
HEI
$49.9B
| $427K | ﹤0.01% |
3,068
+35
| +1% | +$4.83K |
|
927
Uber
UBER
$139B
| $424K | ﹤0.01% |
8,486
-96
| -1% | -$5.01K |
|
928
Coherus Oncology
CHRS
$225M
| $422K | ﹤0.01% |
+30,559
| New | +$433K |
|
929
ESCO Technologies
ESE
$8.4B
| $421K | ﹤0.01% |
4,488
-6,751
| -60% | -$681K |
|
930
Southern Copper
SCCO
$141B
| $421K | ﹤0.01% |
7,082
-174
| -2% | -$11.3K |
|
931
Moderna
MRNA
$22.1B
| $419K | ﹤0.01% |
1,788
-2,050
| -53% | -$366K |
|
932
Teladoc Health
TDOC
$1.61B
| $417K | ﹤0.01% |
2,518
-52
| -2% | -$8.43K |
|
933
ePlus
PLUS
$2.33B
| $416K | ﹤0.01% |
9,614
+292
| +3% | +$13.9K |
|
934
iShares Global 100 ETF
IOO
$8.68B
| $415K | ﹤0.01% |
5,850
| – | – |
|
|
SLAM
935
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $413K | ﹤0.01% |
+42,660
| New | +$416K |
|
936
Mohawk Industries
MHK
$7.05B
| $411K | ﹤0.01% |
2,140
-375
| -15% | -$76.3K |
|
937
Rogers Corp
ROG
$2.31B
| $411K | ﹤0.01% |
2,050
-92
| -4% | -$17.6K |
|
938
AerCap
AER
$23.9B
| $410K | ﹤0.01% |
8,017
| – | – |
|
939
Invesco Biotechnology & Genome ETF
PBE
$282M
| $409K | ﹤0.01% |
5,299
-1,280
| -19% | -$95.1K |
|
940
Keurig Dr Pepper
KDP
$41B
| $407K | ﹤0.01% |
11,569
+259
| +2% | +$9.24K |
|
941
EOG Resources
EOG
$74.7B
| $406K | ﹤0.01% |
4,886
-296
| -6% | -$23.4K |
|
|
VIVO
942
DELISTED
Meridian Bioscience Inc
VIVO
| $406K | ﹤0.01% |
18,320
-882
| -5% | -$18.7K |
|
943
Nuveen Select Tax-Free Income Portfolio
NXP
$897M
| $405K | ﹤0.01% |
22,195
| – | – |
|
|
HOLX
944
DELISTED
Hologic
HOLX
| $402K | ﹤0.01% |
6,036
-261
| -4% | -$17.4K |
|
945
Wabtec
WAB
$50.8B
| $400K | ﹤0.01% |
4,872
-83
| -2% | -$6.74K |
|
946
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.29B
| $399K | ﹤0.01% |
3,885
-380
| -9% | -$38.8K |
|
947
Douglas Dynamics
PLOW
$1.04B
| $399K | ﹤0.01% |
9,824
-265
| -3% | -$11.6K |
|
948
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $397K | ﹤0.01% |
10,130
+1,340
| +15% | +$51.9K |
|
|
JNPR
949
DELISTED
Juniper Networks
JNPR
| $396K | ﹤0.01% |
14,546
-21,178
| -59% | -$564K |
|
950
CRISPR Therapeutics
CRSP
$4.6B
| $394K | ﹤0.01% |
2,441
-22
| -0.9% | -$2.68K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2021 Portfolio in Review
As of Q2 2021, Glenmede Trust held 1,342 positions worth $19.3B, up 4.2% from $18.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust's Q2 2021 filing shows 146 new, 332 increased, 638 reduced and 75 closed positions. Its largest new stake was Virtu Financial: 627,026 shares worth $17.3M. The largest sale was McKesson, an estimated $82.9M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q2 2021 buy was Virtu Financial: 627,026 shares worth $17.3M.
- Glenmede Trust added most to TJX Companies in Q2 2021, an estimated $37.2M increase.
- Glenmede Trust's biggest Q2 2021 reduction was McKesson, cutting an estimated $82.9M.
- Glenmede Trust fully exited Western Alliance Bancorporation in Q2 2021, selling an estimated $19.5M.
- Glenmede Trust's ten largest holdings make up 20% of its $19.3B portfolio in Q2 2021.
- Glenmede Trust opened 146 new positions and closed 75 in Q2 2021.
- Glenmede Trust's portfolio value rose 4.2% quarter-over-quarter to $19.3B.
Based on Glenmede Trust's 13F filing for Q2 2021, filed 16 Aug 2021.